Trending...
- Maybesoon Drops New Music Video for "Hill Street."
- Neurocrine Biosciences to Host Analyst Day on December 5, 2023
- ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Arbor Realty Trust, Inc. Investors to Inquire About Securities Class Action Investigation – ABR
Antimicrobial resistance is one of the biggest public health challenges of our time, and we're at a crossroads on how to combat it.
NEW YORK - Nyenta -- By: Gerald Bloom, Institute of Development Studies in Brighton
It's called the "silent pandemic" and kills more people than HIV/AIDS and malaria combined. Antimicrobial resistance is a serious threat to human health. Already it has had a hand in the deaths of millions, and the numbers could get worse.
How countries take on this threat has wide-ranging repercussions. It will require a new kind of health diplomacy in which nations negotiate rules for cooperation and agree on their responsibilities and entitlements.
In 2019, antimicrobial resistance was directly linked to the death of 1.2 million people and associated with another 5 million. That same year, HIV/AIDS killed around 860,000 people and malaria 640,000.
Antimicrobial resistance is one of the biggest public health challenges of our time, and we're at a crossroads on how to combat it.
More on Nyenta.com
It's called the "silent pandemic" and kills more people than HIV/AIDS and malaria combined. Antimicrobial resistance is a serious threat to human health. Already it has had a hand in the deaths of millions, and the numbers could get worse.
How countries take on this threat has wide-ranging repercussions. It will require a new kind of health diplomacy in which nations negotiate rules for cooperation and agree on their responsibilities and entitlements.
In 2019, antimicrobial resistance was directly linked to the death of 1.2 million people and associated with another 5 million. That same year, HIV/AIDS killed around 860,000 people and malaria 640,000.
The overuse of antibiotics means they have become less effective against serious infections. Drugs no longer work because the bacteria causing infections — such as pneumonia — have become resistant to treatment. There has been relatively little investment in the development of new antibiotics, partly because the use of any new products need to be limited to delay the development of resistance. This means companies cannot generate revenue.
More on Nyenta.com
Many people in low- and middle-income countries still do not have access to antibiotic treatment for common infections. They often rely on local drug sellers who may supply sub-standard products. The same countries face an increasing problem with resistant organisms.
According to a study published in UK medical journal The Lancet, antimicrobial resistance affects the poorest the hardest. Sub-Saharan African nations have the highest fatality rate, at 27.3 deaths per 100,000 people. Infections of the respiratory tract, bloodstream and stomach that were once treatable are now killing hundreds of thousands.
Video Release -
https://rumble.com/v3keru6-antimicrobial-resistance.html?mref=2uj5l2&mc=5efmc
https://rumble.com/account/channel/content?channelId=4749544
It's called the "silent pandemic" and kills more people than HIV/AIDS and malaria combined. Antimicrobial resistance is a serious threat to human health. Already it has had a hand in the deaths of millions, and the numbers could get worse.
How countries take on this threat has wide-ranging repercussions. It will require a new kind of health diplomacy in which nations negotiate rules for cooperation and agree on their responsibilities and entitlements.
In 2019, antimicrobial resistance was directly linked to the death of 1.2 million people and associated with another 5 million. That same year, HIV/AIDS killed around 860,000 people and malaria 640,000.
Antimicrobial resistance is one of the biggest public health challenges of our time, and we're at a crossroads on how to combat it.
More on Nyenta.com
- Empowering Voices: Houston's Black Authors Illuminate the Blockchain World with 'Chain Reaction'
- Bit Digital, Inc. Announces Monthly Production Update for November 2023
- Morgan Stanley China A Share Fund, Inc. Declares a Dividend
- Barker, Pasha and Vokac receive prestigious 54th annual USS Admiral of the Ocean Sea Awards
- New Rochelle: Free 2 Hour Holiday Parking December 1-31
It's called the "silent pandemic" and kills more people than HIV/AIDS and malaria combined. Antimicrobial resistance is a serious threat to human health. Already it has had a hand in the deaths of millions, and the numbers could get worse.
How countries take on this threat has wide-ranging repercussions. It will require a new kind of health diplomacy in which nations negotiate rules for cooperation and agree on their responsibilities and entitlements.
In 2019, antimicrobial resistance was directly linked to the death of 1.2 million people and associated with another 5 million. That same year, HIV/AIDS killed around 860,000 people and malaria 640,000.
The overuse of antibiotics means they have become less effective against serious infections. Drugs no longer work because the bacteria causing infections — such as pneumonia — have become resistant to treatment. There has been relatively little investment in the development of new antibiotics, partly because the use of any new products need to be limited to delay the development of resistance. This means companies cannot generate revenue.
More on Nyenta.com
- New Rochelle: Opportunity Youth Part Initiative (OYP) 3rd Anniversary Celebration
- Unlocking the Magic of Miami Beach
- Introducing Scuba Diving Industry Magazine
- JEGI CLARITY Has Advised Hal Leonard On Its Merger With Muse Group, With Investment From Francisco Partners
- Celebrate the Season with COMFORT & JOY: Glam Rock Soul Christmas Concert by Victor & Aisha Jackson
Many people in low- and middle-income countries still do not have access to antibiotic treatment for common infections. They often rely on local drug sellers who may supply sub-standard products. The same countries face an increasing problem with resistant organisms.
According to a study published in UK medical journal The Lancet, antimicrobial resistance affects the poorest the hardest. Sub-Saharan African nations have the highest fatality rate, at 27.3 deaths per 100,000 people. Infections of the respiratory tract, bloodstream and stomach that were once treatable are now killing hundreds of thousands.
Video Release -
https://rumble.com/v3keru6-antimicrobial-resistance.html?mref=2uj5l2&mc=5efmc
https://rumble.com/account/channel/content?channelId=4749544
Source: 360 Organization
0 Comments
Latest on Nyenta.com
- Rochester: City, USDA Wildlife Services to Disperse Winter Crows
- Pritchard Industries Acquires ACP Facility Services
- KBRA Named Ratings Agency Of The Year at Second Annual SFR Industry Awards
- Coming Up On Fox Business Financial Industry Legend Tom Hegna
- The Museum at FIT Presents Statement Sleeves
- TVA Media Group Joins Powerhouse Agency Network Unite Digital
- KBRA Assigns Preliminary Ratings to MSWF 2023-2
- India Fest 2024 on Jan 27, 2024 at KY Expo Center
- Tune In to Fox Business for an Interview with Short-Term Rental Expert Leslie Anne Morris
- Doug Gillespie Appointed CEO of Beauty By Imagination, Inc.
- Fourth Edition of 'Women's International Champions Cup Best XI Presented by Ally' Team Announced
- Jodee Singz releases new single "Jijem" to all major platforms
- iOT365 Launches Pioneering SaaS Solution for Operational Technology Security
- Genuine Hospitality, LLC Adds the Hampton Inn - Columbia, MO to Growing Portfolio
- OneKey® MLS Board of Managers Welcomes Tom Hurdelbrink, Veteran Real Estate Industry Leader
- REA 'Peace of Mind on the Move' Study achieves Highly Commended recognition in the category Excellence in Coaching by ABP November 2023
- Revolutionizing FEC Chain Stores with Our Cutting-Edge Ordering& Warehousing System
- QuBind.com Makes Major Strides in T-Cell Immunotherapy with Revolutionary AI Innovation
- SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 - (NASDAQ: ILMN)
- Media Personality Cyrus Webb celebrates 20 years and over 12,000 guests on Conversations LIVE radio show